Trials / Withdrawn
WithdrawnNCT05255770
A Clinical Investigation to Assess the Effectiveness of Benzocaine Condoms in Healthy Adult Men
A Double Masked, Randomised, 3-way Cross-over, Single-center, Clinical Investigation to Evaluate the Effectiveness of Two NRL Condoms With Benzocaine Paste Compared With a Standard NRL Control in Prolonging Time to Ejaculation in Healthy Adult Men
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited · Industry
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This investigation is designed to evaluate the effectiveness of two NRL condoms with Benzocaine paste compared with a standard NRL control.
Detailed description
In this clinical investigation, two NRL condoms with Benzocaine paste (Test condom A and Test condom B) will be evaluated against a standard NRL male condom (Control condom) in prolonging time to ejaculation in healthy adult men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Test condom A (NRL condom with 5% benzocaine paste) | In each assessment period (intervention duration), subjects will be provided with a condom type to use during vaginal intercourse and will report at least 4 duration records (from vaginal entry to ejaculation) over a 4-week period. |
| DEVICE | Test condom B (NRL condom with 3% benzocaine paste) | In each assessment period (intervention duration), subjects will be provided with a condom type to use during vaginal intercourse and will report at least 4 duration records (from vaginal entry to ejaculation) over a 4-week period. |
| DEVICE | Control NRL condom | In each assessment period (intervention duration), subjects will be provided with a condom type to use during vaginal intercourse and will report at least 4 duration records (from vaginal entry to ejaculation) over a 4-week period. |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2022-02-25
- Last updated
- 2022-09-16
Source: ClinicalTrials.gov record NCT05255770. Inclusion in this directory is not an endorsement.